Aquestive Therapeutics, Inc.
Nasdaq · CIK 0001398733 · Fiscal year end 1231
Latest reported period: Latest published period
Recent financials
| Metric | Current | Prior | Change |
|---|
Latest filings
| Form | Company | Filed | Accession |
|---|---|---|---|
| 4 | Aquestive Therapeutics, Inc. | 2026-07-17 | 0001214659-26-008663 |
| 4 | Aquestive Therapeutics, Inc. | 2026-06-24 | 0001214659-26-007677 |
| 4 | Aquestive Therapeutics, Inc. | 2026-06-16 | 0001214659-26-007511 |
| 4 | Aquestive Therapeutics, Inc. | 2026-06-09 | 0001214659-26-007262 |
| 4 | Aquestive Therapeutics, Inc. | 2026-05-19 | 0001214659-26-006554 |
| 4 | Aquestive Therapeutics, Inc. | 2026-05-18 | 0001214659-26-006532 |
| 4 | Aquestive Therapeutics, Inc. | 2026-05-18 | 0001214659-26-006527 |
| 10-Q | Aquestive Therapeutics, Inc. | 2026-05-13 | 0001398733-26-000030 |
| 4 | Aquestive Therapeutics, Inc. | 2026-05-11 | 0001214659-26-005932 |
| 4 | Aquestive Therapeutics, Inc. | 2026-05-07 | 0001214659-26-005751 |
| 4 | Aquestive Therapeutics, Inc. | 2026-05-07 | 0001214659-26-005750 |
| 4 | Aquestive Therapeutics, Inc. | 2026-05-07 | 0001214659-26-005749 |
| 4 | Aquestive Therapeutics, Inc. | 2026-05-07 | 0001214659-26-005748 |
| 4 | Aquestive Therapeutics, Inc. | 2026-05-07 | 0001214659-26-005747 |
| 4 | Aquestive Therapeutics, Inc. | 2026-03-11 | 0001214659-26-003147 |
| 4 | Aquestive Therapeutics, Inc. | 2026-03-11 | 0001214659-26-003146 |
| 4 | Aquestive Therapeutics, Inc. | 2026-03-11 | 0001214659-26-003145 |
| 4 | Aquestive Therapeutics, Inc. | 2026-03-11 | 0001214659-26-003144 |
| 4 | Aquestive Therapeutics, Inc. | 2026-03-11 | 0001214659-26-003143 |
| 4 | Aquestive Therapeutics, Inc. | 2026-03-11 | 0001214659-26-003142 |
| 4 | Aquestive Therapeutics, Inc. | 2026-03-11 | 0001214659-26-003141 |
| 4 | Aquestive Therapeutics, Inc. | 2026-03-11 | 0001214659-26-003140 |
| 4 | Aquestive Therapeutics, Inc. | 2026-03-11 | 0001214659-26-003134 |
| 10-K | Aquestive Therapeutics, Inc. | 2026-03-04 | 0001398733-26-000018 |
| 4 | Aquestive Therapeutics, Inc. | 2025-12-05 | 0001214659-25-017652 |
| 4 | Aquestive Therapeutics, Inc. | 2025-12-04 | 0001214659-25-017591 |
| 4 | Aquestive Therapeutics, Inc. | 2025-11-12 | 0001214659-25-016275 |
| 10-Q | Aquestive Therapeutics, Inc. | 2025-11-05 | 0001398733-25-000028 |
| 4 | Aquestive Therapeutics, Inc. | 2025-10-17 | 0001214659-25-015048 |
| 4 | Aquestive Therapeutics, Inc. | 2025-10-17 | 0001214659-25-015047 |
| 4 | Aquestive Therapeutics, Inc. | 2025-10-17 | 0001214659-25-015046 |
| 4 | Aquestive Therapeutics, Inc. | 2025-09-29 | 0001214659-25-014287 |
| 4 | Aquestive Therapeutics, Inc. | 2025-09-29 | 0001214659-25-014288 |
| 4 | Aquestive Therapeutics, Inc. | 2025-09-22 | 0001214659-25-014009 |
| 4 | Aquestive Therapeutics, Inc. | 2025-09-08 | 0001214659-25-013493 |
| 4 | Aquestive Therapeutics, Inc. | 2025-09-08 | 0001214659-25-013485 |
| 4 | Aquestive Therapeutics, Inc. | 2025-08-15 | 0001214659-25-012304 |
| 4 | Aquestive Therapeutics, Inc. | 2025-08-12 | 0001214659-25-011823 |
| 10-Q | Aquestive Therapeutics, Inc. | 2025-08-11 | 0001398733-25-000013 |